IACT Health Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture

Columbus, GA and Piscataway, NJ – (Jan. 23, 2018) — IACT Health, a clinical trial management company dedicated to streamlining study operations for highly efficient clinical trials, and Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that IACT Health has selected Alpha Clinical Systems’ ACS360 eSource platform for clinical trial data capture.

Alpha Clinical Systems will provide the fully-integrated ACS360 platform, including Study Designer and ez-SourceDocx. Using the ACS360 platform, IACT Health will streamline study start-up and execution with web-based study design and tablet-based direct eSource data capture. The ACS360 platform is designed to help streamline study operations by providing truly paperless data capture and real-time access to validated study data, dramatically reducing study timelines and costs.

“IACT Health is excited to begin working with Alpha Clinical Systems in an effort to further streamline study operations via their next-generation ACS360 eSource platform,” said Christine Senn, CIO, IACT Health. “We selected the ACS360 platform because we required an eSource solution that was both comprehensive and affordable, and could deliver real-time, remote access to high-quality study data.”

“IACT Health required a more comprehensive, yet affordable, eSource solution that would streamline and modernize their clinical trials,” said Murthy Gandham, CEO, Alpha Clinical Systems. “We look forward to helping IACT Health deliver high-quality data in real-time via the ACS360 platform.”

Alpha Clinical Systems developed the ACS360 platform to eliminate the challenges of eSource adoption among life science companies. Designed to maximize site efficiency and data quality, the ACS360 platform works with or without existing electronic data capture (EDC) systems to deliver real-time, remote access to validated clinical trial data.

By | 2018-02-09T16:43:14+00:00 January 23rd, 2018|Press Releases|